Skip to content
Independent analysis of NHS open data
PharmaInsight

Ustekinumab

Gastro-Intestinal System Chronic bowel disorders BNF 0105030B0
Data updated December 2021 Download CSV
1items

Dispensed in December 2021

0items

Rolling 12 months

£2,147

Net ingredient cost · December 2021

Figure 1. Ustekinumab: national items dispensed by month

0 0.5 1 Dec 2021 1 Dec 2021: 1

Source: NHSBSA Prescription Cost Analysis, to December 2021

Download CSV
Embed this chart

Free to reuse with the credit line above.

At a glance

  • Therapeutic class Chronic bowel disorders
  • Presentations 1 shown
  • Average cost / item £2,147.00
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, December 2021

The individual products dispensed under Ustekinumab this month.

Presentations of Ustekinumab, December 2021
Presentation BNF code Items Net ingredient cost
Stelara 130mg/26ml concentrate for inf vials 0105030B0BBAAAA 1 £2,147

Source: NHSBSA Prescription Cost Analysis · to December 2021 OGL v3.0

In NHS hospitals

Ustekinumab is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Ustekinumab with

Other medicines in the same BNF section, by prescribing volume.

Ustekinumab vs Mesalazine (Systemic) Ustekinumab vs Sulfasalazine Ustekinumab vs Budesonide Ustekinumab vs Balsalazide sodium Ustekinumab vs Sodium cromoglicate

Download this data

The monthly series for Ustekinumab is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.